News

LVH in Donor Heart Does Not Increase Recipients' Risk of Death


 

FROM THE ANNUAL MEETING OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION

The presence of LVH in a donor heart does not adversely affect the survival of transplant recipients, concluded Dr. Pinzon.

But "organ selection and allocation is not a random process," and transplantation involving hearts with moderate or severe LVH was rare. "This indicates that these patients were carefully selected, which can bias our results," he cautioned; therefore, the safety of using such hearts remains uncertain.

Dr. Pinzon reported that he had no relevant conflicts of interest.

Pages

Recommended Reading

Erythropoietin Bolus After PCI Fails to Reduce Infarct Size
MDedge Internal Medicine
Case Volume Deemed Not a Significant Factor in CABG Outcomes
MDedge Internal Medicine
Persistent LV Hypertrophy Worsens Hypertension Outcomes
MDedge Internal Medicine
New Heart Allocation Algorithm Appears Effective
MDedge Internal Medicine
Data Suggest 70 May Be the New 60 for Heart Transplantation
MDedge Internal Medicine
Nearly Half of ICDs in Massachusetts Placed for Off – Label Indications
MDedge Internal Medicine
A Conclave for a Complex Valve
MDedge Internal Medicine
Reversal Seen in Use of Hearts From High-Risk Donors
MDedge Internal Medicine
Keeping Score on the STS Risk Score
MDedge Internal Medicine
Factors Predict Successful Weaning From VAD
MDedge Internal Medicine